|
Ibuprofen |
|
Trade Name: |
Motrin |
|
Therapeutic Class: |
28:08.04 Nonsteroidal Anti-inflammatory Agents |
|
Contraindications: |
Hypersensitivity to ibuprofen or other NSAIDs; active GI bleeding, ulcer disease |
|
Usual Dosage |
|
Adolescents and Adults |
|
Inflammatory disease: |
|
Oral: |
400-800 mg/dose 3-4 times/day;
maximum dose: 3.2 grams/day |
|
Pain: |
|
Oral: |
400 mg/dose every 4-6 hours to a
maximum of 1.2 grams/day |
|
Dysmenorrhea/fever: |
|
Oral: |
200-400 mg/dose every 4-6 hours to a
maximum dose of 1.2 grams/day |
|
Dosage Form |
|
Tablet: |
200 mg, 400 mg, 600 mg, 800 mg |
|
Authorized Prescribers: |
MD/DDS/NP/PA/RN |
|
Comments: |
RN: can only prescribe 200 mg tablet and use for menstrual pain and non-specific musculo-skeletal pain. NP/PA: can only prescribe 200 mg and 400 mg and use for epididymitis, fibrocystic breasts, lumbosacral strain, cervical neck strain, ankle/knee sprain and DJD |
|
Imipramine |
|
Trade Name: |
Tofranil |
|
Therapeutic Class: |
28:16.04 Antidepressants |
|
Contraindications: |
Narrow-angle glaucoma; hypersensitivity to tricyclic antidepressants; avoid use during pregnancy and lactation |
|
Usual Dosage |
|
Adults: |
|
Oral: |
50-100 mg/24 hours divided 3 times/day; maintenance: 75-300 mg/24 hours divided three times/day |
|
Dosage Form |
|
Tablet: |
10 mg, 25 mg, 50 mg |
|
Authorized Prescribers: |
MD only |
|
Comments: |
None |
|
Immune Globulin |
|
Trade Name: |
Gamimune |
|
Therapeutic Class: |
80:04 Serums |
|
Contraindications: |
Hypersensitivity to immune globulin or any component |
|
Usual Dosage |
|
Adults: |
|
Immunodeficiency syndrome: 100-200 mg/kg/dose every month; may increase to 400 mg/kg as needed |
|
Dosage Form |
|
Injection: |
16.5 mg/ml |
|
Authorized Prescribers: |
MD only |
|
Comments: |
MUST BE REFRIGERATED |
|
Indinavir |
|
Trade Name: |
Crixivan |
|
Therapeutic Class: |
08:18.08 Antiretrovirals |
|
Contraindications: |
Hypersensitivity to indinavir or any component; concomitant use with rifampin is contraindicated since rifampin my markedly reduce indinavir concentrations |
|
Usual Dosage |
|
Adolescents and Adults |
|
Oral: |
800 mg/dose every 8 hours |
|
Dosage Form |
|
Capsule: |
200 mg, 400 mg |
|
Authorized Prescribers: |
MD only |
|
Comments: |
Protease inhibitor of choice for DIHS |
|
Indomethacin |
|
Trade Name: |
Indocin |
|
Therapeutic Class: |
28:08.04 Nonsteroidal Anti-inflammatory Agents |
|
Contraindications: |
Hypersensitivity to indomethacin or any component; active GI bleeding, ulcer disease, impaired renal function, thrombocytopenia |
|
Usual Dosage |
|
Adults: |
|
Oral: |
25-50 mg/dose 2-3 times/day;
maximum dose: 200mg/day |
|
Dosage Form |
|
Capsules: |
25 mg, 50 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Acute gout, cervical neck sprain |
|
Insulin |
|
Trade Name: |
Novolin/Humulin |
|
Therapeutic Class: |
68:20.08 Insulins |
|
Contraindications: |
Hypersensitivity to insulin |
|
Usual Dosage—Diabetes Mellitus |
|
Children and Adults |
|
0.5-1 unit/kg/24 hours |
|
Adolescents during growth spurt |
|
0.8-1.2 units/kg/24 hours |
|
Dosage Form |
|
Novolin/Humulin N |
100 units/ml |
|
Novolin/Humulin 70/30: |
70/30 units/ml |
|
Novolin/Humulin R |
100 units/ml |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Diabetes mellitus |
|
Ipecac |
|
Trade Name: |
Ipecac syrup |
|
Therapeutic Class: |
56:20 Emetics |
|
Contraindications: |
Do not use in unconscious patients, patients with no gag reflex; ingestion of strong bases or acids, volatile oils, seizures |
|
Usual Dosage |
|
Children 6-12 months: |
|
Oral: |
5-10 ml followed by 10-20 ml/kg of water; repeat dose one time if vomiting does not occur within 20 minutes |
|
1-12 years: |
|
Oral: |
15 ml followed by 10-20 ml/kg water; repeat dose one time if vomiting does not occur within 20 minutes |
|
Adults: |
|
Oral: |
30 ml followed by 200-300 ml of water; repeat dose one time if vomiting does not occur within 20 minutes |
|
Dosage Form |
|
Syrup: |
2.1-grams/30 ml |
|
Authorized Prescribers: |
MD/DDS/NP/PA/RN |
|
Comments: |
NP/PA/RN: For use in poisoning as per guidelines |
|
Isoniazid |
|
Trade Name: |
INH |
|
Therapeutic Class: |
08:16 Antituberculosis Agents |
|
Contraindications: |
Acute liver disease; hypersensitivity to isoniazid or any component |
|
Usual Dosage |
|
Daily Dose |
|
Children |
|
Oral: |
10-20 mg/kg/24 hours in 1-2 divided doses |
|
Adults: |
|
Oral: |
5 mg/kg/24 hours given daily (usual dose: 300 mg) |
|
Twice Weekly Dose |
|
Adults: |
|
Oral: |
20-40 mg/kg/dose (up to 900 mg) twice weekly |
|
Adults: |
|
Oral: |
15 mg/kg/dose (up to 900 mg) twice weekly |
|
Dosage Form |
|
Syrup: |
50 mg/5 ml |
|
Tablet: |
100 mg, 300 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: TB prophylaxis. For more information regarding dosing of INH please refer to the DIHS Infectious Disease Management Clinical Guidelines |
|
Isoproterenol |
|
Trade Name: |
Isuprel |
|
Therapeutic Class: |
12:12 Sympathomimetic (Adrenergic) Agents |
|
Contraindications: |
Angina, pre-existing cardiac arrhythmias (ventricular); tachycardia or A-V block caused by cardiac glycoside intoxication; allergy to sulfites or isoproterenol or other
sympathomimetic amines |
|
Usual Dosage |
|
Adults: |
|
Injectable: |
2-20 mcg/minute |
|
Dosage Form |
|
Injectable: |
2 mg/ml |
|
Authorized Prescribers: |
MD only |
|
Comments: |
None |
|
Isosorbide Dinitrate |
|
Trade Name: |
Isordil |
|
Therapeutic Class: |
24:12 Vasodilating Agents |
|
Contraindications: |
Hypersensitivity to isosorbide, nitrates or any components |
|
Usual Dosage |
|
Adults: |
|
Oral: |
5-40 mg three times a day |
|
Dosage Form |
|
Tablet: |
5 mg, 10 mg, 20 mg, 30 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Angina pectoris in adults |
|
Isosorbide Mononitrate |
|
Trade Name: |
ISMO, Monoket, Imdur |
|
Therapeutic Class: |
24:12 Vasodilating Agents |
|
Contraindications: |
Hypersensitivity to isosorbide, nitrates or any components |
|
Usual Dosage |
|
Adults: |
|
Oral: |
10-20 mg twice daily; if using slow release formula dose is 30-120 mg once a day |
|
Dosage Form |
|
Tablet: |
10 mg, 20 mg |
|
Slow Release Formula: |
30 mg, 60 mg, 120 mg |
|
Authorized Prescribers: |
MD/NP/PA |
|
Comments: |
NP/PA: Angina pectoris in adults |
|
|
|
|
|
|
|
|
|